Thyroid Cancer: Can an Ultrasound Scan Help Detect It?

Thyroid Cancer: The Basics

Thyroid cancer is the most common endocrine malignancy in the UK. Cancer Research UK estimates approximately 4,500 new cases per year, with incidence rising steadily over the past two decades — largely due to improved detection of small, incidental nodules on imaging performed for other reasons. The majority of thyroid cancers are papillary thyroid carcinoma, which has an excellent prognosis when detected early: five-year survival rates exceed 98% for localised disease.

Thyroid nodules are common — population studies suggest that up to 68% of adults have at least one detectable nodule on high-resolution ultrasound. The vast majority are benign. The clinical challenge is distinguishing the small proportion of malignant nodules from the large majority of benign ones, and ultrasound is the primary tool for making that distinction.

How Ultrasound Is Used in Thyroid Assessment

Ultrasound is the first-line imaging investigation for any palpable neck lump or suspected thyroid abnormality, recommended by NICE guideline NG12 (Suspected Cancer: Recognition and Referral) and by the British Thyroid Association (BTA) guidelines for the management of thyroid cancer. It provides detailed information about nodule size, composition (solid, cystic, or mixed), echogenicity, margins, calcification pattern, and vascularity — all of which contribute to risk stratification.

Ultrasound does not diagnose thyroid cancer — only histological analysis of a tissue sample can do that. What it does is identify nodules that warrant further investigation (typically fine-needle aspiration cytology, FNAC) and provides reassurance for nodules with a low-risk sonographic appearance.

TI-RADS: How Sonographers Classify Thyroid Nodules

The Thyroid Imaging Reporting and Data System (TI-RADS) is a standardised scoring system that assigns a risk category to each thyroid nodule based on its sonographic features. The ACR TI-RADS system, widely used in UK private practice, assigns points for composition, echogenicity, shape, margin, and echogenic foci, producing a score from TR1 (benign) to TR5 (high suspicion for malignancy). Higher scores trigger recommendations for FNAC biopsy.

At Sonoworld, our thyroid ultrasound reports include TI-RADS classification for all identified nodules, with management recommendations aligned to BTA and ACR guidelines. This means your GP or endocrinologist receives a report that is immediately actionable.

What Happens After a Thyroid Ultrasound?

The management pathway after a thyroid ultrasound depends on the TI-RADS classification and nodule size:

• TR1–TR2 (benign / not suspicious): No further imaging required. Routine clinical follow-up.
• TR3 (mildly suspicious): Follow-up ultrasound in 1–3 years depending on size; FNAC if ≥2.5 cm.
• TR4 (moderately suspicious): FNAC recommended if ≥1.5 cm.
• TR5 (highly suspicious): FNAC recommended if ≥1 cm.

Our written report includes the specific management recommendation for each nodule, based on ACR TI-RADS 2017 criteria. If urgent referral is indicated, we will advise you at the end of the scan.

Private Thyroid Ultrasound at Sonoworld

Our thyroid and neck ultrasound scan is available from £235 at our Marylebone clinic. The scan takes approximately 20 to 30 minutes and includes assessment of the thyroid gland, parathyroid regions, and cervical lymph nodes. Findings are explained verbally at the end of the scan and a written report with TI-RADS classification is sent within 24 hours.

No GP referral is required. If you have a neck lump, hoarseness, difficulty swallowing, or unexplained weight loss alongside neck symptoms, please see your GP first — these symptoms may qualify for an urgent two-week-wait referral on the NHS.

Frequently Asked Questions